+ Follow ANTIVIRAL Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 861128
[Title] => New developments in liver disease
[Summary] => The liver disease session featured four highly regarded experts in the field who provided an outstanding overview.
[DatePublished] => 2012-10-28 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 508460
[Title] => WHO: very few Tamiflu-resistant swine flu cases
[Summary] => GENEVA (AP) — The World Health Organization says 28 swine flu patients worldwide had viruses resistant to Tamiflu, but another antiviral still worked.
[DatePublished] => 2009-09-26 00:01:57
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 466837
[Title] => WHO recommends use of antivirals for high risk groups
[Summary] => GENEVA (Xinhua) -- Since most A/H1N1 flu patients can recover without antiviral treatment, countries are advised to save their antiviral drugs for those people to whom the virus tends to cause more severe and lethal infections, a World Health Organization (WHO) expert said on Tuesday.
[DatePublished] => 2009-05-13 08:09:03
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[3] => Array
(
[ArticleID] => 71282
[Title] => Update on chronic hepatitis C
(Conclusion)
[Summary] =>
[DatePublished] => 2008-07-06 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[4] => Array
(
[ArticleID] => 294946
[Title] => Prevention of hepatitis B virus-related liver cancer (Hepatocellular carcinoma)
[Summary] => The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal vaccination of newborns has been shown to significantly reduce the incidence of HCC among Taiwanese children. Among HBV carriers, the incidence of HCC was significantly higher in those who were hepatitis B e antigen positive, suggesting that antiviral therapy that results in viral clearance or sustained suppression of HBV replication should reduce the incidence of HCC.
[DatePublished] => 2005-09-04 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
ANTIVIRAL
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 861128
[Title] => New developments in liver disease
[Summary] => The liver disease session featured four highly regarded experts in the field who provided an outstanding overview.
[DatePublished] => 2012-10-28 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 508460
[Title] => WHO: very few Tamiflu-resistant swine flu cases
[Summary] => GENEVA (AP) — The World Health Organization says 28 swine flu patients worldwide had viruses resistant to Tamiflu, but another antiviral still worked.
[DatePublished] => 2009-09-26 00:01:57
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 466837
[Title] => WHO recommends use of antivirals for high risk groups
[Summary] => GENEVA (Xinhua) -- Since most A/H1N1 flu patients can recover without antiviral treatment, countries are advised to save their antiviral drugs for those people to whom the virus tends to cause more severe and lethal infections, a World Health Organization (WHO) expert said on Tuesday.
[DatePublished] => 2009-05-13 08:09:03
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[3] => Array
(
[ArticleID] => 71282
[Title] => Update on chronic hepatitis C
(Conclusion)
[Summary] =>
[DatePublished] => 2008-07-06 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[4] => Array
(
[ArticleID] => 294946
[Title] => Prevention of hepatitis B virus-related liver cancer (Hepatocellular carcinoma)
[Summary] => The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal vaccination of newborns has been shown to significantly reduce the incidence of HCC among Taiwanese children. Among HBV carriers, the incidence of HCC was significantly higher in those who were hepatitis B e antigen positive, suggesting that antiviral therapy that results in viral clearance or sustained suppression of HBV replication should reduce the incidence of HCC.
[DatePublished] => 2005-09-04 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
September 26, 2009 - 12:01am